u/Avish_Golakiya · 3h ago7 prior · awaiting results
“Watching, sized as a small speculative position initially”
10 penny biotechs I'm watching and slowly adding for September 2026, and the one I got wrong in August.
CAPR has $544M market cap with 22 months of cash runway and no immediate financing pressure following FDA's decision to extend the PDUFA date to Nov 22 after narrowing the indication. The drug still faces a real bear case—the AdCom voted against it and this is the same data, not new—but the author is watching for upside after being wrong on the August timeline.
Now $9.4015m ago